James E. Hartle

1.5k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

James E. Hartle is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, James E. Hartle has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Transplantation. Recurrent topics in James E. Hartle's work include Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). James E. Hartle is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). James E. Hartle collaborates with scholars based in United States, Switzerland and Denmark. James E. Hartle's co-authors include H. Lester Kirchner, Ion D. Bucaloiu, Robert M. Perkins, Evan Norfolk, L. Darryl Quarles, Suresh Siddhanti, Christopher D. Still, G. Craig Wood, T. K. Hinson and Rong Guo and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Endocrinology.

In The Last Decade

James E. Hartle

27 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury

2011 426 citations Ion D. Bucaloiu, H. Lester Kirchner et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Hartle United States	14	630	242	223	150	117	27	1.2k
Thorsten Feldkamp Germany	25	642 1.0×	261 1.1×	313 1.4×	157 1.0×	89 0.8×	83	1.5k
Yoon-Goo Kim South Korea	17	683 1.1×	286 1.2×	259 1.2×	257 1.7×	152 1.3×	63	1.4k
Sun Moon Kim South Korea	23	421 0.7×	259 1.1×	140 0.6×	158 1.1×	228 1.9×	65	1.3k
Francisco Veríssimo Veronese Brazil	23	548 0.9×	267 1.1×	187 0.8×	109 0.7×	112 1.0×	55	1.2k
Dennis G. Moledina United States	25	1.1k 1.7×	316 1.3×	173 0.8×	259 1.7×	144 1.2×	66	1.8k
Caterina Canavese Italy	23	518 0.8×	152 0.6×	132 0.6×	261 1.7×	95 0.8×	85	1.4k
Carlo Donadio Italy	21	678 1.1×	266 1.1×	119 0.5×	225 1.5×	137 1.2×	87	1.3k
Antoine Buemi Italy	17	568 0.9×	258 1.1×	184 0.8×	192 1.3×	94 0.8×	57	1.2k
François Madore Canada	25	639 1.0×	289 1.2×	146 0.7×	184 1.2×	362 3.1×	73	1.4k
Angel de Francisco Spain	15	610 1.0×	162 0.7×	157 0.7×	147 1.0×	166 1.4×	19	1.7k

Countries citing papers authored by James E. Hartle

Since Specialization

Citations

This map shows the geographic impact of James E. Hartle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Hartle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Hartle more than expected).

Fields of papers citing papers by James E. Hartle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Hartle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Hartle. The network helps show where James E. Hartle may publish in the future.

Co-authorship network of co-authors of James E. Hartle

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Hartle. A scholar is included among the top collaborators of James E. Hartle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Hartle. James E. Hartle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scheinman, Steven J., et al.. (2023). Abigail Geisinger Primary Care Scholars: An Innovative Educational Program Addressing Critical Workforce Needs. SHILAP Revista de lepidopterología. 10. 2347575457–2347575457. 1 indexed citations

Hartle, James E., et al.. (2021). Need for payer-provider partnerships in addressing social determinants of health. Journal of Managed Care & Specialty Pharmacy. 27(6). 791–796. 6 indexed citations

Chang, Alex R., Yuan Chen, Christopher D. Still, et al.. (2016). Bariatric surgery is associated with improvement in kidney outcomes. Kidney International. 90(1). 164–171. 130 indexed citations

Perkins, Robert M., H. Lester Kirchner, Kunihiro Matsushita, et al.. (2014). Bisphosphonates and Mortality in Women with CKD and the Presence or Absence of Cardiovascular Disease. Clinical Journal of the American Society of Nephrology. 9(5). 874–880. 8 indexed citations

Norfolk, Evan & James E. Hartle. (2013). Nephrology Care in a Fully Integrated Care Model. Clinical Journal of the American Society of Nephrology. 8(4). 687–693. 6 indexed citations

Hartle, James E., Xiaoqin Tang, H. Lester Kirchner, et al.. (2012). Bisphosphonate Therapy, Death, and Cardiovascular Events Among Female Patients With CKD: A Retrospective Cohort Study. American Journal of Kidney Diseases. 59(5). 636–644. 31 indexed citations

Bucaloiu, Ion D., H. Lester Kirchner, Evan Norfolk, James E. Hartle, & Robert M. Perkins. (2011). Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney International. 81(5). 477–485. 426 indexed citations breakdown →

Perkins, Robert M., et al.. (2011). GFR Decline and Mortality Risk among Patients with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 6(8). 1879–1886. 91 indexed citations

Park, Alyssa M., Douglas W. Storm, Brant R. Fulmer, et al.. (2009). A Prospective Study of Risk Factors for Nephrolithiasis After Roux-en-Y Gastric Bypass Surgery. The Journal of Urology. 182(5). 2334–2339. 57 indexed citations

10.

Bucaloiu, Ion D., et al.. (2007). Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits.. PubMed. 20(6). 26–30. 19 indexed citations

11.

Malek, Sayeed K., et al.. (2006). Campath-1H Induction and the Incidence of Infectious Complications in Adult Renal Transplantation. Transplantation. 81(1). 17–20. 49 indexed citations

12.

Zhang, Ping L., Sayeed K. Malek, Fan Lin, et al.. (2005). Acute Cellular Rejection Predominated by Monocytes Is a Severe Form of Rejection in Human Renal Recipients With or Without Campath-1H (Alemtuzumab) Induction Therapy. American Journal of Transplantation. 5(3). 604–607. 27 indexed citations

13.

Zhang, Ping L., Santosh Potdar, Sayeed K. Malek, et al.. (2005). Transplantation and 6-Month Follow-up of Renal Transplantation from a Donor with Systemic Lupus Erythematosus and Lupus Nephritis. American Journal of Transplantation. 5(7). 1772–1776. 8 indexed citations

14.

Zhang, Ping L., Taher M. Yahya, Jeffrey W. Prichard, et al.. (2005). Case report: IgM type of membranous glomerulopathy in a diabetic patient.. PubMed. 35(2). 184–8. 3 indexed citations

15.

Zhang, Ping L., Sayeed K. Malek, Fan Lin, et al.. (2004). Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.. PubMed. 34(2). 209–13. 8 indexed citations

16.

Hartle, James E., et al.. (2000). THE ADDITION OF BASILIXIMAB TO CELLCEPT, NEORAL AND STEROIDS RESULTED IN A SIGNIFICANT REDUCTION IN ACUTE RENAL ALLOGRAFT REJECTION.. Transplantation. 69(Supplement). S159–S159. 5 indexed citations

17.

Costello, John M., et al.. (2000). Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation. Transplant International. 13(S1). S27–S30. 23 indexed citations

18.

Quarles, L. Darryl, James E. Hartle, Suresh Siddhanti, Rong Guo, & T. K. Hinson. (1997). A Distinct Cation-Sensing Mechanism in MC3T3-E1 Osteoblasts Functionally Related to the Calcium Receptor. Journal of Bone and Mineral Research. 12(3). 393–402. 96 indexed citations

19.

Siddhanti, Suresh, James E. Hartle, & L. Darryl Quarles. (1995). Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts.. Endocrinology. 136(11). 4834–4841. 38 indexed citations

20.

Quarles, L. Darryl, James E. Hartle, John P. Middleton, et al.. (1994). Aluminum‐Induced DNA synthesis in osteobalsts: Mediation by a G‐protein coupled cation sensing mechanism. Journal of Cellular Biochemistry. 56(1). 106–117. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact